Abstract 2095P
Background
Cancer-related fatigue (CRF) is a significant and frequent problem among cancer patients. There is no gold standard. However, ESMO CPGL 2020 recommended multimodal interventions, CRF is underdiagnosed, undertreated and underdocumented. In this study, we evaluated cancer rehabilitation program including education, physical activity and emotional support.
Methods
Cancer rehabilitation program includes: patients and family education, physical activity (aerobic exercise), water- therapy, yoga, behavioural therapy, relaxation, art, music-therapy, proteinrich nutrition, social support. The Five-time-sit-to-stand test, Hand-Grip-Strength, 6 min walking test, Brief fatigue inventory, Hospital anxiety and Depression scale were used. Descriptive statistics and t-tests.
Results
Participants were 112 patients (48y [29-75]), 60.7% women and 39.2% men. The primary cancer was 26.7 % breast, 16.9% gasrtoesophageal 33.6% colorectal, 16.8% lung, 5.96% pancreatobiliary. Before rehabilitation: the Five-time-sit-to-stand test 10.2 sec (4.5-28.1), Hand-Grip-Strength 28.4 kg, 6 min walking test 482 meters (49,631), Brief fatigue inventory 45 (0-75), Fatique 8/10 (0,10), Cognitive 6, Emotional 4, Physical 6, QoL 4 (0-10). HADS 8 (0, 18). After rehabilitation: the Five-time-sit-to-stand test 5.7 sec (-50%), Hand-Grip-Strength 39.2 kg, 6 min walking test 585 meters (62,822), Brief fatigue inventory 25 (0-58), Fatique 3/10 (0,10), Cognitive 3, Emotional 1, Physical 4, QoL 7 (0-10). HADS 4 (0, 18).
Conclusions
Cancer rehabilitation program including different types of interventions is effective in treating cancer related-fatigue.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06